CD25bright NK cells display superior function and metabolic activity under regulatory T cell-mediated suppression

Infusion of natural killer (NK) cells is an attractive therapeutic modality in patients with cancer. However, the activity of NK cells is regulated by several mechanisms operating within solid tumors. Regulatory T (Treg) cells suppress NK cell activity through various mechanisms including deprivatio...

Full description

Bibliographic Details
Published in:	OncoImmunology
Main Authors:	Ziqing Chen, Le Tong, Shi Yong Neo, Shuijie Li, Jiwei Gao, Susanne Schlisio, Andreas Lundqvist
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2023-12-01
Subjects:	Natural killer cells regulatory T cells IL-15 CD25 tumor microenvironment
Online Access:	https://www.tandfonline.com/doi/10.1080/2162402X.2023.2175517

Similar Items

4‐1BB and cytokines trigger human NK, γδ T, and CD8+ T cell proliferation and activation, but are not required for their effector functions
by: Laurent Vidard
Published: (2023-01-01)

The Cytotoxic Activity of Natural Killer Cells Is Suppressed by IL-10+ Regulatory T Cells During Acute Retroviral Infection
by: Elisabeth Littwitz-Salomon, et al.
Published: (2018-08-01)

IL-2 and IL-15 dependent thymic development of Foxp3-expressing regulatory T lymphocytes
by: Cécile Apert, et al.
Published: (2017-05-01)

INFLUENCE OF HOMEOSTATIC CYTOKINES – IL-7 AND IL-15 ON T-REGULATORY CELLS IN VITRO
by: D. V. Shevyrev, et al.
Published: (2021-10-01)

Implications of a ‘Third Signal’ in NK Cells
by: Mohamed Khalil, et al.
Published: (2021-07-01)

The anti-inflammatory cytokine IL-37 improves the NK cell-mediated anti-tumor response
by: Nadine Landolina, et al.
Published: (2024-12-01)

Twelve-week treadmill endurance training in mice is associated with upregulation of interleukin-15 and natural killer cell activation and increases apoptosis rate in Hepa1-6 cell-derived mouse hepatomas
by: Zhe Wang, et al.
Published: (2023-08-01)

A Self-Activating IL-15 Chimeric Cytokine Receptor to Empower Cancer Immunotherapy
by: Chen S, et al.
Published: (2024-10-01)

Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma
by: Alessandra Zecca, et al.
Published: (2021-03-01)

Correlation of regulatory T cells in chronic lymphocytic leukemia characterized by high-affinity CD25 expression with serum IL-2 values, IGVH mutational status, Rai stage, and therapeutic lines
by: Georgiana Ene, et al.
Published: (2020-09-01)

A novel membrane-bound interleukin-2 promotes NK-92 cell persistence and anti-tumor activity
by: Qi Xiong, et al.
Published: (2022-12-01)

Natural Killer (NK) Cell Education Differentially Influences HIV Antibody-Dependent NK Cell Activation and Antibody-Dependent Cellular Cytotoxicity
by: Nicole F. Bernard, et al.
Published: (2017-08-01)

Dietary lipid overload creates a suppressive environment that impedes the antiviral functions of NK cells
by: Simone Schimmer, et al.
Published: (2025-05-01)

Prognostic significance of perioperative circulating CD56bright NK cell and recovery of NK cell activity in patients with colorectal cancer undergoing radical surgery
by: Jeng-Fu You, et al.
Published: (2025-02-01)

Role of IL-10-Producing Natural Killer Cells in the Regulatory Mechanisms of Inflammation during Systemic Infection
by: Israel Martinez-Espinosa, et al.
Published: (2021-12-01)

Usage of IFNγ or TNFα-T in protocols for obtaining cytokine-induced killer cells for adoptive immunotherapy
by: Yu. V. Gelm, et al.
Published: (2025-03-01)

Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo
by: Renata Nacasaki Silvestre, et al.
Published: (2023-09-01)

IL-10+CD19+ regulatory B cells induce CD4+Foxp3+regulatory T cells in serum of cervical cancer patients
by: Chunfeng Yang, et al.
Published: (2024-12-01)

Regulatory T Cells: Potential Target in Anticancer Immunotherapy
by: Chi-Mou Juang, et al.
Published: (2007-09-01)

The therapeutic effects of human embryonic stem cells-derived immunity-and-matrix regulatory cells on membranous nephropathy
by: Hui-song Zhou, et al.
Published: (2022-06-01)

NK cell receptor profiling of endometrial and decidual NK cells reveals pregnancy-induced adaptations
by: Dorien Feyaerts, et al.
Published: (2024-03-01)

Regulatory NK cells in autoimmune disease
by: Davood Bahadorian, et al.
Published: (2023-06-01)

CD4+CD25+CD127low FoxP3+ regulatory T cells in Crohn’s disease
by: Khalili Ali, et al.
Published: (2018-09-01)

Characterization of IL-10-producing regulatory B cells in thymoma
by: Fangnan Lin, et al.
Published: (2022-08-01)

Phenotypic Profile of Peripheral Blood NK Cells under Culturing with Trophoblast Cells and IL-15 and IL-18 Cytokines
by: V. A. Mikhailova, et al.
Published: (2021-12-01)

Exhausted signature and regulatory network of NK cells in myasthenia gravis
by: Qing Zhang, et al.
Published: (2024-09-01)

Tumor-infiltrating mast cells stimulate ICOS+ regulatory T cells through an IL-33 and IL-2 axis to promote gastric cancer progression
by: Yipin Lv, et al.
Published: (2024-03-01)

Regulatory T cell-mediated control of chronic inflammation
by: Keishi eFujio, et al.
Published: (2012-02-01)

Postoperative Regulatory T-Cells and Natural Killer Cells in Stage I Nonsmall Cell Lung Cancer Underwent Video-assisted Thoracoscopic Lobectomy or Thoracotomy
by: Sai Zhang, et al.
Published: (2015-01-01)

Interleukin-2 is required for NKp30-dependent NK cell cytotoxicity by preferentially regulating NKp30 expression
by: Nayoung Kim, et al.
Published: (2024-04-01)

A New Antibody–Cytokine Construct Targeting Natural Killer Cells: An Immunotherapeutic Approach to Chronic Lymphocytic Leukemia
by: Michela Flego, et al.
Published: (2025-01-01)

The Correlation between NK Cell and Liver Function in Patients with Primary Hepatocellular Carcinoma
Published: (2014-05-01)

New cell sources for CAR-based immunotherapy
by: Marzieh Mazinani, et al.
Published: (2023-05-01)

Hspa13 Deficiency Impaired Marginal Zone B Cells Regulatory Function and Contributed to Lupus Pathogenesis
by: Chen Xing, et al.
Published: (2025-02-01)

Cytotoxicity of Human Cord Blood Natural Killer Cells is Enhanced by Recombinant Interleukin-15
by: Shiva Saghafi, et al.
Published: (2010-06-01)

Imbalance of NK cell subpopulations and polymorphisms of proinflammatory cytokine genes in the pathogenesis of atherosclerosis
by: A. R. Tuguz, et al.
Published: (2022-03-01)

TCR-NK Cells: A Novel Source for Adoptive Immunotherapy of Cancer
by: Zeynep Sena Karahan, et al.
Published: (2023-03-01)

Advances in metabolic reprogramming of NK cells in the tumor microenvironment on the impact of NK therapy
by: Linxuan Miao, et al.
Published: (2024-03-01)

Donor selection for adoptive immunotherapy with NK cells in AML patients: Comparison between analysis of lytic NK cell clones and phenotypical identification of alloreactive NK cell repertoire
by: Raffaella Meazza, et al.
Published: (2023-02-01)

The Advances and Challenges of NK Cell-Based Cancer Immunotherapy
by: Synat Kang, et al.
Published: (2021-02-01)